Royal Bank of Canada’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Royal Bank of Canada’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3	Closed	–	–	7002
2018 Q1	$0	Hold	3	–	–	﹤0.01%	7164
2017 Q4	$0	Sell	3 -125	-98%	-$215	﹤0.01%	7234
2017 Q3	$0	Buy	128 +3	+2%	+$4	﹤0.01%	7219
2017 Q2	$0	Sell	125 -699	-85%	-$1.57K	﹤0.01%	6989
2017 Q1	$2K	Buy	824 +475	+136%	+$2.25K	﹤0.01%	6467
2016 Q4	$2K	Buy	349 +234	+203%	+$4.05K	﹤0.01%	6513
2016 Q3	$2K	Sell	115 -109	-49%	-$2.75K	﹤0.01%	6231
2016 Q2	$6K	Buy	224 +99	+79%	+$2.8K	﹤0.01%	5920
2016 Q1	$4K	Sell	125 -12	-9%	-$326	﹤0.01%	6002
2015 Q4	$5K	Sell	137 -232	-63%	-$10.2K	﹤0.01%	6186
2015 Q3	$18K	Sell	369 -31	-8%	-$2.17K	﹤0.01%	5622
2015 Q2	$28K	Buy	+400	New	+$18.5K	﹤0.01%	5539
2014 Q2	–	Sell	-1	Closed	–	–	6270
2014 Q1	$0	Buy	+1	New	+$25	﹤0.01%	6274
2013 Q4	–	Sell	-1	Closed	–	–	6300
2013 Q3	$0	Buy	+1	New	+$31	﹤0.01%	6364

Other funds holding ANTH

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Royal Bank of Canada's ANTH Position: Q2 2018 in Review

Royal Bank of Canada sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 3 shares.

Royal Bank of Canada first reported a position in ANTH in Q3 2013 and held it in 14 quarters. The position peaked at $28K in Q2 2015. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

Royal Bank of Canada reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Royal Bank of Canada sold 3 Anthera Pharmaceuticals, Inc. shares in Q2 2018.
Royal Bank of Canada first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2013 and held it in 14 quarters.
Royal Bank of Canada's Anthera Pharmaceuticals, Inc. position peaked at $28K in Q2 2015.
5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on Royal Bank of Canada's 13F filing for Q2 2018, filed 14 Aug 2018.